I think the pilot study was just to show the capability of the cpp technology. I cant imagine pyc or anyone else will fund any further research in this area until the ip of omomyc is clarified. At this stage apparently still in dispute. Our hope at the moment is someone else with a drug like omo that has the same problem and needs help getting it into cells. Could come from anywhere I guess. The news has had a while to sink in now so surely if we are on the right path something happens soon???
- Forums
- ASX - By Stock
- PYC
- Ann: Cancer pilot study success
Ann: Cancer pilot study success, page-100
Featured News
Add PYC (ASX) to my watchlist
(20min delay)
|
|||||
Last
19.0¢ |
Change
0.005(2.70%) |
Mkt cap ! $886.5M |
Open | High | Low | Value | Volume |
18.5¢ | 19.0¢ | 17.5¢ | $508.8K | 2.763M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 118941 | 18.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
19.0¢ | 183634 | 2 |
Last trade - 16.10pm 14/11/2024 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |
Day chart unavailable
The Watchlist
BTH
BIGTINCAN HOLDINGS LIMITED
David Keane, Co-Founder & CEO
David Keane
Co-Founder & CEO
Previous Video
Next Video
SPONSORED BY The Market Online